Peptides DB
Research-centric peptide and protocol reference hub
Study 39 of 41SS-31 literatureCell metabolism · ObservationalTop journal2015

Reversal of Mitochondrial Transhydrogenase Causes Oxidative Stress in Heart Failure.

The study suggests that targeting Nnt-mediated oxidative stress with SS-31 could potentially impact mortality in heart failure, but further research in humans is necessary.

Read at Cell metabolismAdd to compare

Where it sits

this study against the rest of the ss-31 corpus
3
Preclinical
29
Observational · this one
0
Open-label
4
Randomised
5
Reviews

Summary and findings

This study examined the role of mitochondrial reactive oxygen species (ROS) in heart failure, particularly focusing on the nicotinamide nucleotide transhydrogenase (Nnt) enzyme. The tetrapeptide SS-31 was investigated for its potential to rescue mortality in a mouse model of pressure overload-induced heart failure. The findings suggest a link between Nnt function and oxidative stress in heart failure.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2015

Abstract

The authors’ words, as Cell metabolism supplied them

Mitochondrial reactive oxygen species (ROS) play a central role in most aging-related diseases. ROS are produced at the respiratory chain that demands NADH for electron transport and are eliminated by enzymes that require NADPH. The nicotinamide nucleotide transhydrogenase (Nnt) is considered a key antioxidative enzyme based on its ability to regenerate NADPH from NADH. Here, we show that pathological metabolic demand reverses the direction of the Nnt, consuming NADPH to support NADH and ATP production, but at the cost of NADPH-linked antioxidative capacity. In heart, reverse-mode Nnt is the dominant source for ROS during pressure overload. Due to a mutation of the Nnt gene, the inbred mouse strain C57BL/6J is protected from oxidative stress, heart failure, and death, making its use in cardiovascular research problematic. Targeting Nnt-mediated ROS with the tetrapeptide SS-31 rescued mortality in pressure overload-induced heart failure and could therefore have therapeutic potential in patients with this syndrome.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the SS-31 corpus

CMitochondrial dysfunction drives age-related degeneration of the thoracic aorta.GeroScience · 2026 · Not reported in abstract.AnimalCTargeting Mitochondrial Dysfunction With Elamipretide (SS-31) Improves Skeletal Muscle Performance in a HFpEF Rat Model.Circulation. Heart failure · 2026 · +173.2% single-fiber contractile function in soleus, p<0.001AnimalCNovel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation.Circulation · 2024 · Infarct size increased to 48±7% with VA-ECMO compared to 36±8% with reperfusion alone, P<0.001.AnimalCStructural and functional characterisation of the dextran utilisome from Bacteroides thetaiotaomicron.Journal of structural biology: X · 2026 · Not reported in abstract.In vitroC4-oxo-quinoline based fluorescent chemosensors for on-site detection of G-type nerve agent mimic DCP via spectroscopic and theoretical insights.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2026 · Limit of detection for DCP: 0.14 μM for 6DEQA.In vitroDEffectiveness of virtual reality-based rehabilitation on quality of life and upper extremity functions among stroke survivors: A systematic review and meta-analysis.International journal of nursing studies advances · 2026 · SMD = -0.09, 95% CI -0.30 to 0.11, p = .36; low certainty for QoL.review